Literature DB >> 1902751

Cancer treatment: deciding what we can afford.

G J Rees.   

Abstract

Mesh:

Year:  1991        PMID: 1902751      PMCID: PMC1669180          DOI: 10.1136/bmj.302.6780.799

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  The management of oesophageal carcinoma: radiotherapy or surgery? Cost considerations.

Authors:  Q J Walker; G Salkeld; J Hall; I O'Rourke; C A Bull; K W Tiver; A O Langlands
Journal:  Eur J Cancer Clin Oncol       Date:  1989-11

2.  How much can the NHS afford to spend to save a life or avoid a severe disability?

Authors:  C J Roberts; S C Farrow; M C Charny
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

3.  Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.

Authors:  L Jaakkimainen; P J Goodwin; J Pater; P Warde; N Murray; E Rapp
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

4.  Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.

Authors:  A Goldhirsch; R D Gelber; R J Simes; P Glasziou; A S Coates
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

  4 in total
  2 in total

1.  Quality and cost in the palliative care of cancer.

Authors:  B W Hancock
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

2.  The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma.

Authors:  J Fisken; R C Leonard; M Stewart; G J Beattie; C Sturgeon; L Aspinall; J E Roulston
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.